On Friday, January 7, 2022, Stephan Bancel, CEO of a vaccine against Covid-19 called Moderna, started that the efficacy of the booster shots against the contagious mutant will likely decline with time. To save themselves from the deadly virus and its variant called Omicron, people might need the fourth shot.
While speaking at the Goldman Scatch-organized healthcare conference, Bancel informed that their company is working on the vaccine against the new variant named Omicron, but they are unsure whether the vaccine will be ready or available within two months.
“I still believe that people need booster shots at the end of 2022 and further, remarked Bancel.
He further urged that people who have received their booster shots in the last year can fight the viral infection in winters as the virus shows its surge in the seasons due to the large indoor gatherings.
Although, While stressing upon the strength of the booster shots, he mentioned that the efficacy of the booster shots against the viral infection would likely decline over several months. It was exactly what happened to the first two doses. “I want to enclose that we will be surprised when the data of efficacy of the vaccines will come out in the upcoming weeks that it Is effective and holding nicely over time, and I would expect that it is not going to keep great, “highlighted by Bancel.
His comment on the necessity of the fourth booster shot came after the statement of the Israeli Prime Minister asserted the importance of the fourth booster dose against the Covid-19 pandemic. On Tuesday, PM Naftali Bennet cited that the fourth dose of booster shots against the contagious mutant will boost the antibodies in our body fivefold a week after the person get the jab.
Oxford vaccine expert Sir Andrew Pollard also urged,” To vaccinate people after every six months is not sustainable. We can’t vaccinate the entire population over the planet every four to six months, as it is not affordable or sustainable. Today, the need of your is that we have to focus on vulnerable class as in the low-income only 10 percent people have merely had their first jab of the vaccine against the deadly infection”.